LEDERMAN SETH

PrivateCIK: 1563420
Location

NEW YORK, NY

LEDERMAN SETH (Chief Executive Officer) purchased 42.0% of their position (35K shares) of TONIX PHARMACEUTICALS HOLDING CORP. on the open market

Open‑market purchase worth $23.8K — a major conviction buy. The strongest form of insider conviction signal.

P · 1 purchase
InsiderLEDERMAN SETHCIK 1563420
DirectorOfficer· Chief Executive Officer
Since Jun 2018
+35K
Net shares
Net buyer
$23.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
35K acquired
Non-Derivative Transactions1

Common Stock, $0.001 par value

Direct
P · Purchase

Shares

+35K

Price / share

$0.68

Trade value

$23.80K

% of position

42.0%
12/30/2020
83.27K118.27K
Total

Net shares

+35K

Net value

$23.80K

Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)8

Common Stock, $0.001 par value

Indirect
Shares owned31.00

Common Stock, $0.001 par value

Direct
Shares owned177.00

Common Stock, $0.001 par value

Indirect
Shares owned205.00

Common Stock, $0.001 par value

Indirect
Shares owned59.00

Common Stock, $0.001 par value

Direct
Shares owned459.00

Common Stock, $0.001 par value

Indirect
Shares owned30.00

Common Stock, $0.001 par value

Indirect
Shares owned33.00

Common Stock, $0.001 par value

Indirect
Shares owned30.00
Total
636.00 direct·388.00 indirect1.02K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
LEDERMAN SETH — Insider Transaction (Form 4) Filed Jan 4, 2021 | Finecho